VISITING HOSPITAL

All hospital visitors are encouraged to wear a medical face mask. Expand this message for information about visiting hospital. 

Last updated:
31 October 2024

Some visitor restrictions for all Health New Zealand | Te Whatu Ora Waitaha Canterbury hospitals and health facilities remain in place, but we have relaxed others.

There is still a heightened risk to vulnerable people in hospital and we encourage all people wear a mask when visiting any of our facilities and follow other advice designed to keep patients, staff and visitors safe.

To keep everybody safe:

  • Visitors or support people are advised to not visit our facilities if they are unwell. We advise that you do not visit if you have recently tested positive for COVID-19 and haven’t completed your isolation period.
  • Patients may have more than one visitor, except in some situations such as multi-bed rooms where it can cause overcrowding.
  • Surgical/medical masks are encouraged to be worn at all sites. Masks will be provided if you don’t have one.
  • Please practice hand hygiene with provided alcohol-based hand rub/gel

Thank you in advance for your patience and understanding as our staff work hard to protect and care for some of the most vulnerable in our community.

Visiting patients with COVID-19

  • People can visit patients who have COVID-19 but they must wear a surgical mask as a minimum – please use surgical masks provided.

All of our Hospitals

Visiting hours for our hospitals have returned to pre COVID-19 hours.

All visitors are encouraged to wear a medical face mask.

Parents/caregivers can be with their child in hospital and visitors are now allowed, except for the Children’s Haematology and Oncology Day stay where visitor restrictions might apply.

Patients and visitors can also read the additional COVID-19 related visiting guidelines .

Clinical drug trials

  1. Home
  2. About us
  3. Document Library
  4. Clinical drug trials

Official information request details

The number of clinical drug trials your DHB hosted in the 2017/2018 financial year + ongoing trials in 2019. Could figures please be broken-down by:

  1. The number of sponsored clinical trials involving devices and pharmaceuticals. 
  2. Phase 1 first-man-in clinical trials and phase 2a/b safety and efficacy trials, phase 3 broader efficacy trials and phase 4 post-marketing surveillance. And whether these trials are investigator-initiated or industry-sponsored commercially contracted trials.
  3. Investigator-initiated studies of non-therapeutic interventions, e.g. new diagnostics or new applications of existing diagnostics.
  4. Investigator-initiated observational studies including epidemiologic studies.
  5. Can you please also provide the aggregate income figure your DHB obtained from trials conducted in the 2017/2018 financial year.

 

Tags

Download pdf (300KB)

Back to Document Library

Page last updated: 26 June 2019

Is this page useful?